For the quarter ended September 30, 2024, the Company had a loss from operations of $2.3 million, a 26% year-over-year improvement from $3.1 million for the comparable period of 2023, and a 9% ...

In the world of cell therapy, Silicon Valley has long recognized that technological innovation is the key to solving ...

PHAT is a facial rejuvenation therapy that combines nanofat and its stem cells with PRP for anti-aging that lasts for more ...

Instead of sending tourists to space, scientists have found a more practical use for the final frontier: growing better ...

is an allogeneic cell therapy derived from cardiosphere cells, which are connective tissue cells from the heart. The cells ...

(NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced that it has ...

Regenerative medicine is rapidly developing and is already being applied in most countries worldwide. However, the best ...

ALLO-316, a CD70-targeting CAR T-cell therapy, has demonstrated activity in patients with previously treated, advanced ccRCC.

This is the first commercially available small particle detector on a cell sorter and offers a significant advancement for rapidly evolving research fields, including in drug delivery, cell therapy, ...

Researchers from the Center for Regenerative Medicine (CReM) and the Department of Medicine at Boston Medical Center (BMC) ...

A new therapy may delay Alzheimer's disease progression by years, according to a study by researchers at Texas A&M University ...

In an era where wellness technology is rapidly evolving, the Kala Red Light Therapy device stands out as a revolutionary ...